Cargando…
环孢素A联合达那唑±沙利度胺治疗原始细胞不增高骨髓增生异常综合征的疗效及其影响因素分析
OBJECTIVE: To explore the outcome of cyclosporine A(CsA)combined with danazol with or without thalidomide regimen for myelodysplastic syndrome(MDS)with low-percentage bone marrow blasts and predictive factors for treatment response. METHODS: Data of 115 subjects who were newly diagnosed with primary...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293001/ https://www.ncbi.nlm.nih.gov/pubmed/34218579 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.05.005 |
Ejemplares similares
-
芦可替尼联合泼尼松、沙利度胺和达那唑治疗骨髓纤维化的探索性研究
Publicado: (2019) -
环孢素联合沙利度胺治疗IPSS低危/中危-1骨髓增生异常综合征远期疗效影响因素分析
Publicado: (2015) -
沙利度胺联合环磷酰胺和地塞米松治疗症状性华氏巨球蛋白血症的前瞻性临床研究
Publicado: (2023) -
36例T细胞淋巴瘤患者一线应用沙利度胺治疗的临床分析
Publicado: (2016) -
来那度胺治疗伴DDX41胚系突变骨髓增生异常综合征伴原始细胞增多一例报告并文献复习
Publicado: (2020)